ID30039A - Manik-manik baru farmasi pelepasan terkontrol metode pembuatannya dan formulasi berbagai unit yang mengandungnya - Google Patents
Manik-manik baru farmasi pelepasan terkontrol metode pembuatannya dan formulasi berbagai unit yang mengandungnyaInfo
- Publication number
- ID30039A ID30039A IDW00200101038A ID20011038A ID30039A ID 30039 A ID30039 A ID 30039A ID W00200101038 A IDW00200101038 A ID W00200101038A ID 20011038 A ID20011038 A ID 20011038A ID 30039 A ID30039 A ID 30039A
- Authority
- ID
- Indonesia
- Prior art keywords
- control pharmaceutical
- formulation
- various units
- units containing
- control
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9803871A SE9803871D0 (sv) | 1998-11-11 | 1998-11-11 | Therapeutic method and formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
ID30039A true ID30039A (id) | 2001-11-01 |
Family
ID=20413266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW00200101038A ID30039A (id) | 1998-11-11 | 1999-11-11 | Manik-manik baru farmasi pelepasan terkontrol metode pembuatannya dan formulasi berbagai unit yang mengandungnya |
Country Status (40)
Country | Link |
---|---|
US (1) | US6911217B1 (id) |
EP (1) | EP1128819B1 (id) |
JP (1) | JP3616011B2 (id) |
KR (1) | KR100467384B1 (id) |
CN (1) | CN1169522C (id) |
AP (1) | AP1323A (id) |
AR (1) | AR027815A1 (id) |
AT (1) | ATE247458T1 (id) |
AU (1) | AU762410B2 (id) |
BG (1) | BG65149B1 (id) |
BR (1) | BRPI9915142B8 (id) |
CA (1) | CA2350061C (id) |
CZ (1) | CZ299582B6 (id) |
DE (1) | DE69910604T2 (id) |
DK (1) | DK1128819T3 (id) |
EA (1) | EA005074B1 (id) |
EE (1) | EE05232B1 (id) |
ES (1) | ES2204193T3 (id) |
GE (1) | GEP20022833B (id) |
HK (1) | HK1040917B (id) |
HR (1) | HRP20010333B1 (id) |
HU (1) | HU226582B1 (id) |
ID (1) | ID30039A (id) |
IL (1) | IL142809A0 (id) |
IS (1) | IS2370B (id) |
MA (1) | MA25325A1 (id) |
MY (1) | MY122195A (id) |
NO (1) | NO331399B1 (id) |
NZ (1) | NZ511430A (id) |
OA (1) | OA11673A (id) |
PL (1) | PL195780B1 (id) |
PT (1) | PT1128819E (id) |
RS (1) | RS49891B (id) |
SE (1) | SE9803871D0 (id) |
SI (1) | SI1128819T1 (id) |
SK (1) | SK284758B6 (id) |
TW (2) | TWI222879B (id) |
UA (1) | UA57165C2 (id) |
WO (1) | WO2000027364A1 (id) |
ZA (1) | ZA200103575B (id) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU728395B2 (en) * | 1996-07-19 | 2001-01-11 | Gunnar Aberg | S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders |
US8563522B2 (en) | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
EP0957073A1 (en) | 1998-05-12 | 1999-11-17 | Schwarz Pharma Ag | Novel derivatives of 3,3-diphenylpropylamines |
CN100353935C (zh) * | 1999-11-11 | 2007-12-12 | 法马西雅公司 | 含托特罗定的药物制剂及其应用 |
MXPA05002302A (es) * | 2002-08-28 | 2005-06-08 | Pharmacia Corp | Composicion liquida oral de tolterodina. |
US8168170B2 (en) | 2002-10-03 | 2012-05-01 | The Procter And Gamble Company | Compositions having an inner core and at least three surrounding layers |
MXPA05007767A (es) * | 2003-01-22 | 2006-01-31 | Pfizer Health Ab | Dosis reducida de tolterodina y otros agentes antimuscarinicos para tratar trastornos urinarios. |
DE10315917A1 (de) * | 2003-04-08 | 2004-11-18 | Schwarz Pharma Ag | Hochreine Basen von 3,3-Diphenylpropylaminmonoestern |
WO2004112756A1 (en) | 2003-06-26 | 2004-12-29 | Isa Odidi | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
ATE493981T1 (de) | 2003-11-04 | 2011-01-15 | Supernus Pharmaceuticals Inc | Einmal tägliche dosierformen von trospium |
US8709476B2 (en) | 2003-11-04 | 2014-04-29 | Supernus Pharmaceuticals, Inc. | Compositions of quaternary ammonium compounds containing bioavailability enhancers |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US20050152884A1 (en) | 2003-12-19 | 2005-07-14 | The Procter & Gamble Company | Canine probiotic Bifidobacteria globosum |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US7785635B1 (en) | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
US8894991B2 (en) | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
US8394409B2 (en) * | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
EP1629834A1 (en) | 2004-08-27 | 2006-03-01 | KRKA, D.D., Novo Mesto | Sustained release pharmaceutical composition of tolterodine |
EP1836156A1 (en) * | 2005-01-10 | 2007-09-26 | Teva Gyogyszergyar Reszvenytarsasag | Substantially pure tolterodine tartrate and process for preparing thereof |
PL1885383T3 (pl) | 2005-05-31 | 2017-06-30 | Iams Europe B.V. | Kocie probiotyczne bifidobakterie |
WO2006130187A1 (en) | 2005-05-31 | 2006-12-07 | The Iams Company | Feline probiotic lactobacilli |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
US8298574B2 (en) | 2006-01-18 | 2012-10-30 | Intec Pharma Ltd. | Method and apparatus for forming delivery devices for oral intake of an agent |
CA2882048C (en) | 2006-02-03 | 2020-03-24 | Proventiv Therapeutics, Llc | Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3 |
KR100714058B1 (ko) * | 2006-02-06 | 2007-05-02 | 한국유나이티드제약 주식회사 | 톨테로딘 엘-주석산염의 서방형 경구투여 조성물 및 이의 제조 방법 |
KR20080099334A (ko) * | 2006-02-24 | 2008-11-12 | 테바 파마슈티컬 인더스트리즈 리미티드 | 메토프로롤 숙시네이트 서방정 및 이의 제조 방법 |
MX2008011952A (es) * | 2006-03-21 | 2008-10-01 | Teva Pharma | Formulacion de liberacion controlad de tolterodina. |
EP1839649A1 (en) * | 2006-03-31 | 2007-10-03 | LEK Pharmaceuticals D.D. | Coated formulations for tolterodine |
CN101453993A (zh) * | 2006-04-03 | 2009-06-10 | 伊萨·奥迪迪 | 含有机溶胶涂层的受控释放递送物件 |
WO2007122015A1 (en) * | 2006-04-21 | 2007-11-01 | Synthon B.V. | Tolterodine beads |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
EP2026766A1 (en) | 2006-05-17 | 2009-02-25 | Synthon B.V. | Tablet composition with a prolonged release of tamsulosin |
ES2497494T3 (es) | 2006-06-21 | 2014-09-23 | Opko Renal, Llc | Método de tratamiento y prevención del hiperparatiroidismo secundario |
JP2008007458A (ja) * | 2006-06-29 | 2008-01-17 | Freunt Ind Co Ltd | レイヤリング用核粒子とその製造方法 |
MX2009005478A (es) | 2006-11-27 | 2009-08-12 | Lundbeck & Co As H | Derivados de heteroarilamida. |
JP5799299B2 (ja) | 2007-02-01 | 2015-10-21 | ザ・アイムス・カンパニーThe Iams Company | ブドウ糖代謝拮抗物質、アボカド又はアボカド抽出物を使用する、哺乳動物における炎症及びストレスの低下方法 |
WO2008134523A1 (en) | 2007-04-25 | 2008-11-06 | Proventiv Therapeutics, Llc | Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease |
KR20190028822A (ko) | 2007-04-25 | 2019-03-19 | 사이토크로마 인코포레이티드 | 비타민 d 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물 |
WO2009047644A2 (en) | 2007-04-25 | 2009-04-16 | Cytochroma Inc. | Method of treating vitamin d insufficiency and deficiency |
US20090017111A1 (en) * | 2007-07-03 | 2009-01-15 | Van Den Heuvel Dennie J M | Tolterodine bead |
US8110226B2 (en) * | 2007-07-20 | 2012-02-07 | Mylan Pharmaceuticals Inc. | Drug formulations having inert sealed cores |
US8486452B2 (en) * | 2007-07-20 | 2013-07-16 | Mylan Pharmaceuticals Inc. | Stabilized tolterodine tartrate formulations |
US8871275B2 (en) | 2007-08-08 | 2014-10-28 | Inventia Healthcare Private Limited | Extended release compositions comprising tolterodine |
PL2187873T3 (pl) * | 2007-08-13 | 2019-01-31 | Abuse Deterrent Pharmaceutical Llc | Leki odporne na nadużywanie, metoda stosowania i metoda wytwarzania |
US20090192228A1 (en) * | 2008-01-28 | 2009-07-30 | Actavis Group Ptc Ehf | Controlled-Release Tolterodine Compositions and Methods |
US20090214665A1 (en) * | 2008-02-26 | 2009-08-27 | Lai Felix S | Controlled Release Muscarinic Receptor Antagonist Formulation |
CA2629099A1 (en) * | 2008-04-01 | 2009-10-01 | Pharmascience Inc. | Novel oral controlled release pharmaceutical formulations |
US8962239B2 (en) | 2008-04-02 | 2015-02-24 | Opko Renal, Llc | Methods useful for vitamin D deficiency and related disorders |
WO2009140557A2 (en) * | 2008-05-14 | 2009-11-19 | Capricorn Pharma, Inc. | Modified release tolterodine formulations |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
US8465770B2 (en) | 2008-12-24 | 2013-06-18 | Synthon Bv | Low dose controlled release tablet |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
AU2010277207B2 (en) * | 2009-07-31 | 2014-06-26 | Sun Pharmaceutical Industries Limited | Multi-layered, multiple unit pharmaceutical compositions |
WO2011061616A2 (en) | 2009-11-23 | 2011-05-26 | Micro Labs Limited | Extended release compositions containing tolterodine and process for preparing the same |
WO2011095388A1 (en) | 2010-02-04 | 2011-08-11 | Synthon Bv | Tolterodine bead |
JO3112B1 (ar) | 2010-03-29 | 2017-09-20 | Ferring Bv | تركيبة دوائية سريعة التحلل |
JP5736031B2 (ja) | 2010-03-29 | 2015-06-17 | フェリング ベスローテン フェンノートシャップ | 速溶解性医薬組成物 |
PT2552484T (pt) | 2010-03-29 | 2020-04-03 | Opko Ireland Global Holdings Ltd | Métodos e composições para redução dos níveis de parafróides |
US8748433B2 (en) | 2010-04-30 | 2014-06-10 | Merck Sharp & Dohme Corp. | β3 adrenergic receptor agonists |
US20120040008A1 (en) * | 2010-08-11 | 2012-02-16 | Ashish Chatterji | Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists |
US20120289560A1 (en) * | 2011-05-10 | 2012-11-15 | Theravida, Inc. | Combinations of tolterodine and salivary stimulants for the treatment of overactive bladder |
GR1007628B (el) | 2011-07-27 | 2012-06-29 | Φαρματεν Αβεε, | Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου |
AU2012307530B2 (en) | 2011-09-16 | 2016-12-08 | Ferring B.V. | A fast dissolving pharmaceutical composition |
WO2013047795A1 (ja) * | 2011-09-30 | 2013-04-04 | アステラス製薬株式会社 | 粒子状医薬組成物 |
AU2013289403B2 (en) | 2012-07-12 | 2017-05-11 | Ferring B.V. | Diclofenac formulations |
WO2014047477A2 (en) * | 2012-09-20 | 2014-03-27 | Sks Ocular, Llc | Multilayer biodegradable microparticles for sustained release of therapeutic agents |
TW201422254A (zh) | 2012-11-21 | 2014-06-16 | Ferring Bv | 用於速釋及延釋的組成物 |
US20150306170A1 (en) * | 2012-11-21 | 2015-10-29 | Ferring B.V. | Composition for immediate and extended release |
WO2014159051A1 (en) * | 2013-03-13 | 2014-10-02 | Advanced Bionutrition Corp. | Stable bioactive substances and methods of making |
KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 d 방출 제형 |
US11571390B2 (en) | 2013-03-15 | 2023-02-07 | Othemo Life Sciences, Inc. | Abuse deterrent compositions and methods of use |
AU2014246617A1 (en) | 2013-12-23 | 2015-07-09 | Sun Pharmaceutical Industries Limited | Multi-layered, multiple unit pharmaceutical compositions |
EP3193925A2 (en) | 2014-08-07 | 2017-07-26 | OPKO Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin d |
US10729685B2 (en) | 2014-09-15 | 2020-08-04 | Ohemo Life Sciences Inc. | Orally administrable compositions and methods of deterring abuse by intranasal administration |
CA3018328A1 (en) * | 2014-10-31 | 2016-04-30 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
EP3431107A4 (en) * | 2016-02-23 | 2019-11-13 | Nipro Corporation | PARTICULARS OF A PHARMACEUTICAL COMPOSITION AND MOUTH-DISTURBING PREPARATION THEREOF |
IL290855B1 (en) | 2016-03-28 | 2024-02-01 | Eirgen Pharma Ltd | Treatment methods using vitamin D |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1144911B (it) * | 1981-03-19 | 1986-10-29 | Pharmatec Spa | Composizione farmaceutica a rilascio controllato contenente ibuprofen |
JPH07107450A (ja) | 1993-10-08 | 1995-04-21 | Hitachi Ltd | 情報通信装置 |
JP3453186B2 (ja) | 1994-04-14 | 2003-10-06 | 共和薬品工業株式会社 | 徐放性マイクロカプセルおよびその製造方法 |
SE9402422D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New beads for controlled release and a pharmaceutical preparation containing the same |
US5645858A (en) * | 1994-10-06 | 1997-07-08 | Ortho Pharmaceutical Corporation | Multilayered controlled release pharmaceutical dosage form |
US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
AU728395B2 (en) | 1996-07-19 | 2001-01-11 | Gunnar Aberg | S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders |
US6312728B1 (en) * | 1998-07-07 | 2001-11-06 | Cascade Development, Inc. | Sustained release pharmaceutical preparation |
-
1998
- 1998-11-11 SE SE9803871A patent/SE9803871D0/xx unknown
-
1999
- 1999-11-11 SK SK625-2001A patent/SK284758B6/sk not_active IP Right Cessation
- 1999-11-11 CN CNB998132160A patent/CN1169522C/zh not_active Expired - Lifetime
- 1999-11-11 GE GEAP19995939A patent/GEP20022833B/en unknown
- 1999-11-11 RS YUP-331/01A patent/RS49891B/sr unknown
- 1999-11-11 IL IL14280999A patent/IL142809A0/xx unknown
- 1999-11-11 NZ NZ511430A patent/NZ511430A/en not_active IP Right Cessation
- 1999-11-11 PT PT99971702T patent/PT1128819E/pt unknown
- 1999-11-11 EE EEP200100254A patent/EE05232B1/xx unknown
- 1999-11-11 KR KR10-2001-7005879A patent/KR100467384B1/ko active IP Right Grant
- 1999-11-11 MY MYPI99004911A patent/MY122195A/en unknown
- 1999-11-11 HU HU0105038A patent/HU226582B1/hu unknown
- 1999-11-11 EA EA200100538A patent/EA005074B1/ru not_active IP Right Cessation
- 1999-11-11 DE DE69910604T patent/DE69910604T2/de not_active Expired - Lifetime
- 1999-11-11 JP JP2000580595A patent/JP3616011B2/ja not_active Expired - Lifetime
- 1999-11-11 CZ CZ20011627A patent/CZ299582B6/cs not_active IP Right Cessation
- 1999-11-11 EP EP99971702A patent/EP1128819B1/en not_active Expired - Lifetime
- 1999-11-11 UA UA2001042824A patent/UA57165C2/uk unknown
- 1999-11-11 PL PL99348612A patent/PL195780B1/pl unknown
- 1999-11-11 DK DK99971702T patent/DK1128819T3/da active
- 1999-11-11 BR BRPI9915142A patent/BRPI9915142B8/pt not_active IP Right Cessation
- 1999-11-11 US US09/763,281 patent/US6911217B1/en not_active Expired - Lifetime
- 1999-11-11 AU AU14366/00A patent/AU762410B2/en not_active Expired
- 1999-11-11 SI SI9930411T patent/SI1128819T1/xx unknown
- 1999-11-11 AP APAP/P/2001/002166A patent/AP1323A/en active
- 1999-11-11 AR ARP990105734A patent/AR027815A1/es active IP Right Grant
- 1999-11-11 AT AT99971702T patent/ATE247458T1/de active
- 1999-11-11 CA CA002350061A patent/CA2350061C/en not_active Expired - Lifetime
- 1999-11-11 OA OA1200100112A patent/OA11673A/en unknown
- 1999-11-11 ID IDW00200101038A patent/ID30039A/id unknown
- 1999-11-11 ES ES99971702T patent/ES2204193T3/es not_active Expired - Lifetime
- 1999-11-11 WO PCT/SE1999/002052 patent/WO2000027364A1/en active IP Right Grant
-
2000
- 2000-02-11 TW TW089102338A patent/TWI222879B/zh not_active IP Right Cessation
- 2000-02-11 TW TW089102332A patent/TWI267385B/zh not_active IP Right Cessation
-
2001
- 2001-05-03 ZA ZA200103575A patent/ZA200103575B/en unknown
- 2001-05-09 IS IS5936A patent/IS2370B/is unknown
- 2001-05-10 HR HR20010333A patent/HRP20010333B1/xx not_active IP Right Cessation
- 2001-05-10 NO NO20012314A patent/NO331399B1/no not_active IP Right Cessation
- 2001-06-08 MA MA26228A patent/MA25325A1/fr unknown
- 2001-06-08 BG BG105582A patent/BG65149B1/bg unknown
-
2002
- 2002-04-04 HK HK02102521.2A patent/HK1040917B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID30039A (id) | Manik-manik baru farmasi pelepasan terkontrol metode pembuatannya dan formulasi berbagai unit yang mengandungnya | |
ID22426A (id) | Ketobenzamida yang baru dan penggunaannya | |
ID21806A (id) | Bentuk penakaran farmasi yang secara cepat dilepaskan dan yang menutup rasa | |
FI20001087A (fi) | Monikomponenttiset superabsorbentit geelipartikkelit | |
ID28653A (id) | Kolom gelembung udara dan penggunannya | |
ID18925A (id) | Penggunaan benzazol-benzazol yang disubstitusi sebagai absorben-absorben uv, benzazol-benzazol baru dan proses-proses untuk pembuatannya | |
ID22490A (id) | Benzamida-benzamida yang disubstitusi secara heterosiklik yang baru dan penggunaannya | |
ID26248A (id) | Turunan asiguanidina baru sebagai inhibitor penyerapan tulang dan sebagai antagonis reseptor vitronektin | |
ID19479A (id) | Turunan-turunan amidino baru dan pemakaian sebagai penghambat-penghambat trombin | |
ID25469A (id) | Komposisi sefalosporin amorf yang stabil secara kristalografi dan proses pembuatannya | |
ID17128A (id) | Granulat untuk pembuatan komposisi-komposisi cepat mengurai dan cepat larut yang mengandung jumlah obat yang tinggi | |
NO984094L (no) | Utladningsreaktor og anvendelse av samme | |
ID27558A (id) | Amida-amida aromatik baru, metode pembuatannya dan penggunaannya sebagai obat | |
ID24714A (id) | Turunan tiazolidindion tersubstitusi, proses pembuatannya dan penggunaan bahan farmasinya | |
HUP0000189A3 (en) | Bicyclic aryl carboxamides pharmaceutical compositions containing them and their therapeutic use | |
ID20604A (id) | Polisakarida sintetis proses untuk pembuatan dan komposisi farmasi yang dikandungnya | |
ID22283A (id) | Kombinasi terapi baru dari zat-zat mirtazapin dan antipsikotik untuk perawatan atau propilaksis gangguan psikotik | |
ID24259A (id) | Formulasi obat yang memiliki pelepasan senyawa aktif terkontrol | |
ID18682A (id) | Asiltransferase dan plasma yang mengkodekan asiltransferase | |
ID22911A (id) | Turunan-turunan triazol baru, proses pembuatan dan komposisi-komposisi farmasi yang mengandungnya | |
ID24716A (id) | Formulasi baru | |
ID17199A (id) | Mikro-organisme pengurai hidrokarbon yang mengandung halogen dan pemakaiannya | |
DE69420178T2 (de) | Flüssigkeitsauftragegerät und Herstellung desselben | |
ID19050A (id) | Turunan-turunan asam karboksilat yang baru, pembuatannya dan penggunaannya | |
ID20967A (id) | Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut |